Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Desamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real Life Survey of the Sicilian Myeloma Network

Blood (2018) 132 (Supplement 1): 5636.

https://doi.org/10.1182/blood-2018-99-116452

Published: 2018

Journal Articles

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

Giuseppe Milone, MD, Massimo Poidomani, MD, Salvatore Leotta, MD, Valeria Pinto, MD, Andrea Spadaro, Rita Lombardo, MD, Giovanni Tripepi, MD

Blood (2011) 118 (21): 4568.

https://doi.org/10.1182/blood.V118.21.4568.4568

Published: 2011

Journal Articles

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Giuseppe Milone, Salvatore Leotta, Giuseppe Avola, Massimo Poidomani, Maria Grazia Camuglia and Andrea Spadaro

Blood (2010) 116 (21): 4563.

https://doi.org/10.1182/blood.V116.21.4563.4563

Published: 2010

Journal Articles

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Giuseppe Milone, MD, Benedetto Farsaci, MD, Giuseppe Avola, BD, Salvatore Mercurio, BD, Aurora Strano, BD, Maria Grazia Camuglia, BD, Valeria Pinto, MD, Antonella Privitera, BD, Salvatore Leotta, MD, Massimo Poidomani, MD, Stefania Coppoletta, MD, Elisa Mauro, MD, Pamela Murgano, MD, Katia Battiato, MD, Andrea Spataro, MD, Anna Triolo, MD, Rosario Giustolisi, MD

Blood (2007) 110 (11): 2849.

https://doi.org/10.1182/blood.V110.11.2849.2849

Published: 2007

Journal Articles

Adverse Events after Infusions of Cryopreserved Hematopoietic Stem Cells Depend on Non-Mononuclear Cell in Infused Suspension and on Patient Age.

Giuseppe Milone, MD, Valeria Pinto, MD, Salvatore Mercurio, MD, Aurora Strano, MD, Stefania Coppoletta, MD, Benedetto Farsaci, MD, Massimo Poidomani, MD, Salvatore Leotta, MD, Rosario Giustolisi, Md

Blood (2006) 108 (11): 5244.

https://doi.org/10.1182/blood.V108.11.5244.5244

Published: 2006

Journal Articles

Efficacy of Caspofungin as Secondary Prophylaxis in Patients Undergoing Stem Cell Transplantation with Prior Pulmonary and/or Systemic Fungal Infection.

Paolo de Fabritiis, MD, Laura Cudillo, MD, Paolo Di Bartolomeo, MD, Anna Locasciulli, MD, Giuseppe Milone, MD, Stefania Fallani, PhD, Alessandro Busca, MD, Rosanna Scimè, MD, Simona Sica, MD, Alessandra Spagnoli, Statistic, Stella Santarone, MD, Ignazio Majolino, MD, Massimo Poidomani, MD, Andrea Novelli, PhD

Blood (2005) 106 (11): 3225.

https://doi.org/10.1182/blood.V106.11.3225.3225

Published: 2005

NARROW

Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Desamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real Life Survey of the Sicilian Myeloma Network

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Adverse Events after Infusions of Cryopreserved Hematopoietic Stem Cells Depend on Non-Mononuclear Cell in Infused Suspension and on Patient Age.

Efficacy of Caspofungin as Secondary Prophylaxis in Patients Undergoing Stem Cell Transplantation with Prior Pulmonary and/or Systemic Fungal Infection.

Email alerts

ASH Publications

American Society of Hematology

Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Desamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real Life Survey of the Sicilian Myeloma Network

Palifermin In High Dose Chemotherapy and Autologous Stem Cell Transplantation: Reduction of Infections and of Resources Utilization with No Increase in Overall Cost

AML Patients In First CR with Intermediate Risk Cytogenetic and High Level of CD34+ Mobilization Have Better DFS After Allogeneic Transplantation.

Failure of CD34+ Mobilization in AML Patients Is Associated to an Abnormally High Chemosensitivity of Non Leukemic CFU-GM.

Adverse Events after Infusions of Cryopreserved Hematopoietic Stem Cells Depend on Non-Mononuclear Cell in Infused Suspension and on Patient Age.

Efficacy of Caspofungin as Secondary Prophylaxis in Patients Undergoing Stem Cell Transplantation with Prior Pulmonary and/or Systemic Fungal Infection.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only